BlackRock LifePath® Index 2030 Fund Institutional Shares
LINIX
NASDAQ
Weiss Ratings | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | BlackRock | |||
Manager/Tenure (Years) | Christopher Chung (4), Michael Pensky (0), Peter Tsang (0) | |||
Website | http://www.blackrock.com | |||
Fund Information | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | BlackRock LifePath® Index 2030 Fund Institutional Shares | |||
Category | Target-Date 2030 | |||
Sub-Category | Target Date | |||
Prospectus Objective | Asset Allocation | |||
Inception Date | May 31, 2011 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,000,000.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 2.72% | |||
Dividend | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 2.26% | |||
Asset Allocation | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 1.43% | |||
Stock | 50.75% | |||
U.S. Stock | 34.22% | |||
Non-U.S. Stock | 16.53% | |||
Bond | 47.05% | |||
U.S. Bond | 43.85% | |||
Non-U.S. Bond | 3.20% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.76% | |||
Price History | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 1.33% | |||
30-Day Total Return | 0.40% | |||
60-Day Total Return | -0.45% | |||
90-Day Total Return | 0.05% | |||
Year to Date Total Return | 1.98% | |||
1-Year Total Return | 9.05% | |||
2-Year Total Return | 20.71% | |||
3-Year Total Return | 19.80% | |||
5-Year Total Return | 48.08% | |||
Price | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $17.43 | |||
1-Month Low NAV | $16.18 | |||
1-Month High NAV | $17.43 | |||
52-Week Low NAV | $16.18 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $18.13 | |||
52-Week High Price (Date) | Dec 06, 2024 | |||
Beta / Standard Deviation | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.68 | |||
Standard Deviation | 12.16 | |||
Balance Sheet | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 12.67B | |||
Operating Ratios | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.14% | |||
Turnover Ratio | 26.00% | |||
Performance | LINIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 11.73% | |||
Last Bear Market Total Return | -11.42% | |||